Altre lingue BIOLASE, Inc.

Azioni

BIOL

US0909117022

Mercato chiuso - Nasdaq Altri mercati azionari 22:30:01 03/05/2024			Variaz. 5gg	Var. 1 gen.
0,1451 ^USD	-2,22%		-1,96%	-87,07%

01/04	BIOLASE, INC. : Ascendiant Capital mantiene la raccomandazione Buy	ZM
22/03	Wall Street si appresta ad aprire marginalmente in ribasso venerdì dopo il discorso di Powell, dopo aver toccato massimi record giovedì	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Wall Street Set to Open Marginally Lower Friday Following Powell Speech, After Hitting Record Highs Thursday	22/03
US Stock Futures Flat Ahead of Powell Speech After Reaching Record Highs on Thursday	22/03
Top Premarket Gainers	22/03
Biolase: Q4 Earnings Snapshot	21/03
BIOLASE, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2024	21/03
BIOLASE, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	21/03
BIOLASE TO REPORT FOURTH QUARTER AND FULL YEAR 2023 RESULTS ON MARCH 21, 2024	15/03
BIOLASE LAUNCHES STATE-OF-THE-ART ALL-TISSUE LASER SYSTEM TO ACCELERATE ADOPTION OF LASERS IN DENTISTRY	23/02
BIOLASE ANNOUNCES FIRST QUARTER 2024 WEBINAR SERIES 'LETS TALK DENTAL'	21/02
BIOLASE, INC. GRANTED EXTENSION BY NASDAQ TO REGAIN COMPLIANCE WITH THE STOCKHOLDERS EQUITY CONTINUED LISTING REQUIREMENT	15/02
Biolase Prices $7 Million Public Offering	13/02
BIOLASE REPORTS UNAUDITED REVENUE GROWTH FOR FULL YEAR 2023 AND PROVIDES OUTLOOK FOR FULL YEAR 2024	30/01
BIOLASE, Inc. Provides Earnings Guidance for the Full-Year 2023	29/01
BIOLASE, Inc. Provides Earnings Guidance for the Year 2024	29/01
Dr. Carol Gomez Summerhays Intends to Resign as Member of the Board of Directors of Biolase, Inc	29/12
BIOLASE, Inc. Successfully Concludes Waterlase iPlus All Tissue Laser Trial	12/12
BIOLASE, Inc. Announces Pricing of $1.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	06/12
Biolase, Inc. Enters into the Eleventh Amendment to Credit Agreement with SWK Funding LLC	17/11
BIOLASE, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Biolase: Q3 Earnings Snapshot	09/11

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue BIOLASE, Inc.

Azioni

BIOL

US0909117022

Altre lingue

Filtri